Caitong International Asset Management Co., LTD Tyra Biosciences, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 503 shares of TYRA stock, worth $5,180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
503Holding current value
$5,180% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
118Shares Held
55.5MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$110 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$42.7 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$42 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$41.8 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$41.8 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $432M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...